HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Weiguo Xu Selected Research

Weiguo Xu Research Topics

Disease

48Neoplasms (Cancer)
05/2022 - 12/2012
11Hepatocellular Carcinoma (Hepatoma)
11/2021 - 12/2013
8Neoplasm Metastasis (Metastasis)
10/2021 - 01/2005
7Carcinoma (Carcinomatosis)
01/2022 - 04/2014
6Osteosarcoma (Osteogenic Sarcoma)
05/2022 - 01/2004
6Breast Neoplasms (Breast Cancer)
07/2021 - 12/2014
6Inflammation (Inflammations)
01/2020 - 06/2015
5Tuberculosis (Tuberculoses)
10/2017 - 01/2010
4Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 01/2017
4Carcinogenesis
07/2021 - 06/2015
4Prostatic Neoplasms (Prostate Cancer)
05/2018 - 05/2013
3Reperfusion Injury
01/2022 - 12/2020
3Colonic Neoplasms (Colon Cancer)
12/2020 - 06/2014
3Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 10/2017
2Autoimmune Diseases (Autoimmune Disease)
01/2022 - 09/2019
2Liver Neoplasms (Liver Cancer)
01/2022 - 06/2018
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021 - 05/2019
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2021 - 12/2020
2Ischemia
01/2021 - 09/2011
2Sarcoma (Soft Tissue Sarcoma)
01/2020 - 01/2018
2Bacterial Infections (Bacterial Infection)
09/2019 - 05/2018
2Stomach Neoplasms (Stomach Cancer)
01/2019 - 04/2014
2Necrosis
12/2018 - 01/2018
2Fibrosis (Cirrhosis)
06/2018 - 01/2017
2Latent Infection
10/2017 - 03/2015
2Latent Tuberculosis
10/2017 - 03/2015
2Infections
10/2017 - 01/2016
2Asthma (Bronchial Asthma)
01/2017 - 01/2012
2Cicatrix (Scar)
03/2015 - 01/2008
2Hypoxia (Hypoxemia)
06/2014 - 01/2012
1Hypersensitivity (Allergy)
01/2022
1Fistula
01/2022
1Pneumonia (Pneumonitis)
01/2022

Drug/Important Bio-Agent (IBA)

16Pharmaceutical PreparationsIBA
05/2022 - 05/2014
12polyethylene glycol polyethyleneimine nanogelIBA
05/2022 - 01/2015
12MicellesIBA
01/2020 - 11/2013
10Doxorubicin (Adriamycin)FDA LinkGeneric
11/2021 - 05/2014
9Peptides (Polypeptides)IBA
01/2020 - 01/2016
7PolymersIBA
05/2022 - 06/2015
6Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2004
5Biocompatible Materials (Biomaterials)IBA
05/2022 - 11/2009
5Antineoplastic Agents (Antineoplastics)IBA
12/2020 - 11/2013
4Polysaccharides (Glycans)IBA
08/2020 - 06/2015
4homocamptothecinIBA
01/2020 - 10/2017
4ProdrugsIBA
01/2018 - 04/2015
4AcidsIBA
12/2016 - 04/2015
3VaccinesIBA
12/2021 - 01/2010
3Biological ProductsIBA
07/2021 - 12/2019
3CytokinesIBA
01/2019 - 01/2010
3DisulfidesIBA
06/2018 - 05/2014
3Tuberculin (PPD)IBA
10/2017 - 03/2015
3InterferonsIBA
10/2017 - 03/2015
3Dextrans (Dextran)FDA Link
12/2016 - 04/2015
2Oxygen (Dioxygen)IBA
05/2022 - 01/2018
2Transfer RNA (tRNA)IBA
01/2022 - 01/2021
2MicroRNAs (MicroRNA)IBA
11/2021 - 01/2021
2CalciumIBA
10/2021 - 04/2021
2Cisplatin (Platino)FDA LinkGeneric
09/2021 - 04/2021
2Long Noncoding RNAIBA
07/2021 - 01/2021
2Messenger RNA (mRNA)IBA
01/2021 - 06/2015
2Circular RNAIBA
01/2021 - 01/2020
2Cytostatic AgentsIBA
12/2020 - 06/2018
2LipidsIBA
10/2020 - 06/2015
2GoldIBA
10/2020 - 10/2017
2Stimuli Responsive PolymersIBA
08/2020 - 01/2016
2shikoninIBA
01/2020 - 01/2018
2PPAR deltaIBA
01/2019 - 01/2019
2CateninsIBA
01/2019 - 01/2016
2Ethylene Glycol (Monoethylene Glycol)IBA
12/2018 - 01/2016
2Cystine (L-Cystine)IBA
06/2018 - 01/2016
210-hydroxycamptothecinIBA
06/2018 - 10/2017
2Phenylalanine (L-Phenylalanine)FDA Link
06/2018 - 01/2016
2OximesIBA
01/2018 - 06/2015
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2017 - 06/2015
2SmokeIBA
01/2017 - 01/2017
2ginsenoside Rg1IBA
01/2017 - 01/2017
2monomethoxypolyethylene glycol (MPEG)IBA
01/2016 - 11/2015
2Bortezomib (Velcade)FDA Link
12/2015 - 04/2015
2Glutathione (Reduced Glutathione)IBA
01/2015 - 12/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2014 - 01/2004
2DNA VaccinesIBA
11/2012 - 01/2010
1HydrogelsIBA
05/2022
11,2-distearoylphosphatidylethanolamine (DSPE)IBA
05/2022
1MineralsIBA
05/2022
1NeonicotinoidsIBA
01/2022
1imidaclopridIBA
01/2022
1InsecticidesIBA
01/2022
1clothianidinIBA
01/2022
1Alkenes (Olefins)IBA
01/2022
1acetamipridIBA
01/2022
1dinotefuranIBA
01/2022
1Guanidine (Guanidine Nitrate)FDA Link
01/2022

Therapy/Procedure

21Therapeutics
05/2022 - 11/2013
20Drug Therapy (Chemotherapy)
11/2021 - 01/2015
3Immunotherapy
10/2021 - 09/2019
2Precision Medicine
10/2021 - 04/2021
2Combination Drug Therapy (Combination Chemotherapy)
01/2020 - 09/2015
2Intravenous Injections
01/2018 - 11/2015
1Artificial Respiration (Mechanical Ventilation)
01/2022
1Ganglionectomy
01/2022